REWIND trial established CV benefit in primary prevention-like populations Exenatide (Byetta, Bydureon): Once a day injection
CrossRef The multidimensional role of SLC16A4 in hepatocellular carcinoma in silico analysis: prognostic significance, metabolic pathways, and immune microenvironment regulation Lili Jiang, Yi Shen, Zhengyang Feng, Yong Wang, Yaqun Zhu, Yuntian Shen, Qiliang Peng European Journal of Medical Research .2025;[Epub] CrossRef The potential of soluble programmed cell death-ligand 1 and soluble programmed cell death 1 as diagnostic and prognostic biomarkers for hepatocellular carcinoma: a meta-analysis Jie Li, Xiangyang He, Tingting Gao, Qingjun Zhang, Xu Han Irish Journal of Medical Science (1971 -) .2025
These symptoms typically occur during dose escalation and often diminish over time as the body adjusts to the medication
Given the complexity of aging, a multi-faceted approach that includes both antioxidant support (like NAC) and metabolic enhancement (via NAD precursors) might be most beneficial
